Evidence map›Paper›PMID 40415960›Full record

ArticleFrontiers in cellular and infection microbiology2025

Emergence and characterization of a ST852

Chongmei Tian, Yaping Zhao, Su Dong, Zhixin You, Jingbai Chen, Hongfeng Xu, Yuejuan Fang, Yapei Zhang

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chongmei TianDepartment of Pharmacy, Shaoxing Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Shaoxing, Zhejiang, China.
Yaping ZhaoDepartment of Pharmacy, Shaoxing Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Shaoxing, Zhejiang, China.
Su DongDepartment of Clinical Laboratory, Shaoxing Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Shaoxing, Zhejiang, China.
Zhixin YouDepartment of Respiratory Medicine, Shaoxing Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Shaoxing, Zhejiang, China.
Jingbai ChenDepartment of Pharmacy, Shaoxing Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Shaoxing, Zhejiang, China.
Hongfeng XuPharmacy Department of Chinese Medicine, Shaoxing Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Shaoxing, Zhejiang, China.
Yuejuan FangDepartment of Pharmacy, Quzhou Maternal and Child Health Care Hospital, Quzhou, China.
Yapei ZhangDepartment of Clinical Laboratory, Zhejiang Hospital, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To characterize a rare ST852 Methods: Minimum inhibitory concentrations (MICs) were measured using a VITEK 2 compact system and broth microdilution. Conjugation experiments were conducted using film matings. Whole genome sequencing (WGS) was performed using Illumina and Nanopore platforms. Antimicrobial resistance determinants were identified using the ABRicate program in the ResFinder database. Insertion sequences (ISs) were identified using ISFinder. Bacterial virulence factors were identified using a virulence factor database (VFDB). Genome function annotation and classification were further analyzed using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Cluster of Orthologous Groups (COG) databases. Capsular polysaccharides (KL) and lipooligosaccharides (OCL) were tested using Kleborate with the Results: Conclusions: This is the first study to identify an ST852 NDM-1-KPC-2 coproducing

Indexed as

beta-LactamasesKlebsiellaKlebsiella InfectionsAnti-Bacterial AgentsChinaDrug Resistance, Multiple, BacterialGenome, BacterialHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPhylogenyPlasmidsVirulence FactorsWhole Genome SequencingAnti-Bacterial Agentsbeta-lactamase KPC-2beta-lactamase NDM-1beta-LactamasesVirulence FactorsKPC-2K. quasipneumoniaeNDM-1plasmid structureST852WGS

Identifiers

PMID40415960
PMCPMC12098455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.